Rare genetic cause of peritoneal mesothelioma points to targeted therapy
Mesothelioma is a rare and aggressive tumor that, in many cases, results from exposure to asbestos.
Category: Asbestos / Mesothelioma
Mesothelioma shows promising response to existing immunotherapy drug
Malignant pleural mesothelioma shows a promising response to treatment with the antibody drug pembrolizumab, which is used to treat other cancers.
Active agent from the Caribbean sea cucumber could improve treatment for malignant pleural mesothelioma
Researchers at the Comprehensive Cancer Center of MedUni Vienna and Vienna General Hospital have discovered a new option for treating malignant pleural mesothelioma.
Active agent from the Caribbean sea cucumber could improve treatment for malignant pleural mesothelioma
Researchers at the Comprehensive Cancer Center of MedUni Vienna and Vienna General Hospital have discovered a new option for treating malignant pleural mesothelioma.
Landmark asbestosis ruling is good news for sufferers, UK
Court of Appeal rules entitlement to proportional compensation from as low as 2.3%.
Landmark asbestosis ruling is good news for sufferers, UK
Court of Appeal rules entitlement to proportional compensation from as low as 2.3%.
New Zealand Enacts National Asbestos Ban
New Zealand will prohibit importation of all asbestos products and materials beginning Oct. 1, joining 57 other countries that already ban asbestos. Nick Smith, New Zealand environment minister, announced the latest prohibition last week. His statement marked progress toward a long-sought, worldwide ban on the toxic mineral. “It’s about bloody time,” Laurie Kazan-Allen, coordinator of…
The post New Zealand Enacts National Asbestos Ban appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.
New Zealand Enacts National Asbestos Ban
New Zealand will prohibit importation of all asbestos products and materials beginning Oct. 1, joining 57 other countries that already ban asbestos. Nick Smith, New Zealand environment minister, announced the latest prohibition last week. His statement marked progress toward a long-sought, worldwide ban on the toxic mineral. “It’s about bloody time,” Laurie Kazan-Allen, coordinator of…
The post New Zealand Enacts National Asbestos Ban appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.
New Zealand Enacts National Asbestos Ban
New Zealand will prohibit importation of all asbestos products and materials beginning Oct. 1, joining 57 other countries that already ban asbestos. Nick Smith, New Zealand environment minister, announced the latest prohibition last week. His statement marked progress toward a long-sought, worldwide ban on the toxic mineral. “It’s about bloody time,” Laurie Kazan-Allen, coordinator of…
The post New Zealand Enacts National Asbestos Ban appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.
Mesothelioma surgery improves quality of life, study finds
Although surgery can prolong the lives of patients with an aggressive type of cancer called malignant pleural mesothelioma, many patients avoid the operation for fear it will degrade their quality…
Mesothelioma surgery improves quality of life, study finds
Although surgery can prolong the lives of patients with an aggressive type of cancer called malignant pleural mesothelioma, many patients avoid the operation for fear it will degrade their quality…
Immunotherapy with live bacterium improves response rate in malignant pleural mesothelioma
Immunotherapy with a live bacterium combined with chemotherapy demonstrated more than 90% disease control and 59% response rate in patients with malignant pleural mesothelioma (MPM), according to…
Immunotherapy with live bacterium improves response rate in malignant pleural mesothelioma
Immunotherapy with a live bacterium combined with chemotherapy demonstrated more than 90% disease control and 59% response rate in patients with malignant pleural mesothelioma (MPM), according to…
Mesothelioma gene-targeting drug looks hopeful
A new study shows that HOX genes are significantly disrupted in malignant mesothelioma, and targeting them with a drug called HXR9 stopped tumors of the cancer growing in mice.
Mesothelioma gene-targeting drug looks hopeful
A new study shows that HOX genes are significantly disrupted in malignant mesothelioma, and targeting them with a drug called HXR9 stopped tumors of the cancer growing in mice.